2nd Apr 2014 10:52
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.
On 31 March 2014, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £16.08 per Ordinary Share, and notional ADSs at a price of $53.75 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 January 2014 to 31 March 2014:
Non Executive Director | Ordinary Shares | American Depositary Shares (ADSs) |
Sir Christopher Gent | 3,886.816 | |
Professor Sir Roy Anderson | 563.588 | |
Dr Stephanie Burns |
| 433.042 |
Stacey Cartwright | 446.984 | |
Lynn Elsenhans | 779.475 | |
Judy Lewent | 367.144 | |
Sir Deryck Maughan | 1,092.019 | |
Dr Daniel Podolsky | 819.014 | |
Tom de Swaan | 408.116 | |
Jing Ulrich | 216.521 | |
Hans Wijers | 446.984 | |
Sir Robert Wilson | 446.984 | |
The Company and the Non-Executive Directors were informed of these allocations on 1 April 2014.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
2 April 2014
Related Shares:
Glaxosmithkline